Skip to main content

Advertisement

SpringerLink
Log in

Evaluation of the efficacy of atorvastatin in the treatment for chronic subdural hematoma: a meta-analysis

  • Original Article
  • Published:
Neurosurgical Review Aims and scope Submit manuscript

Abstract

Atorvastatin therapy in chronic subdural hematoma patients has attracted more and more clinical attention. To evaluate the efficacy of atorvastatin in the treatment of chronic subdural hematoma. A systematic literature search was performed in the PubMed, Embase, and Cochrane Library databases; related controlled trials comparing the efficacy of atorvastatin in the treatment of chronic subdural hematoma published from inception to December 2018 were collected. We used Cochrane risk of bias method to evaluate the quality of the included studies. Meta-analysis was used to analyze the included data by RevMan 5.3 software. Of the 53 retrieved studies, 6 trials were included. Results of meta-analysis showed that compared with chronic subdural hematoma patients without atorvastatin treatment, both in patients who have had surgery and those who have not, atorvastatin were effective in reducing the incidence of recurrence requires surgery (OR = 0.30, 95% CI 0.19–0.48, P < 0.00001). And improve the recovery rate of neurological function of patients (OR = 1.75, 95% CI 1.08–2.83, P = 0.02). This meta-analysis suggests that patients with chronic subdural hematoma can improve their prognosis after receiving atorvastatin. Additionally, the neurological function recovery appears to be improving by atorvastatin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Miranda LB, Braxton E, Hobbs J, Quigley MR (2011) Chronic subdural hematoma in the elderly: not a benign disease. J Neurosurg 114(1):72–76

    Article  Google Scholar 

  2. Wang D, Jiang R, Liu L, Dong JF, Zhang JN (2010) Membrane neovascularization and drainage of subdural hematoma in a rat model. J Neurotrauma 27(8):1489–1498

    Article  Google Scholar 

  3. Liu L, Wei H, Chen F, Wang J, Dong JF, Zhang J (2011) Endothelial progenitor cells correlate with clinical outcome of traumatic brain injury. Crit Care Med 39(7):1760–1765

    Article  Google Scholar 

  4. Song Y, Wang Z, Liu L, Wang D, Zhang J (2013) The level of circulating endothelial progenitor cells may be associated with the occurrence and recurrence of chronic subdural hematoma. Clinics (Sao Paulo) 68(8):1084–1088

    Article  Google Scholar 

  5. Chen J, Cui X, Zacharek A, Chopp M (2009) Increasing Ang1/Tie2 expression by simvastatin treatment induces vascular stabilization and neuroblast migration after stroke. J Cell Mol Med 13(7):1348–1357

    Article  CAS  Google Scholar 

  6. Chen J, Zacharek A, Li A, Cui X, Roberts C, Lu M, Chopp M (2008) Atorvastatin promotes presenilin-1 expression and Notch1 activity and increases neural progenitor cell proliferation after stroke. Stroke 39(1):220–226

    Article  CAS  Google Scholar 

  7. Ma Y, Chen Z, Zou Y et al (2014) Atorvastatin represses the angiotensin 2-induced oxidative stress and inflammatory response in dendritic cells via the PI3K/Akt/Nrf 2 pathway. Oxidative Med Cell Longev 2014:148798

    Article  Google Scholar 

  8. Chan DYC, Sun DTF, Chan DTM et al (2016) A prospective pilot study on the efficacy of Atorvastatin on chronic subdural haematoma. Surg Pract 20:10–11

    Google Scholar 

  9. Liu H, Luo Z, Liu Z et al (2016) Atorvastatin may attenuate recurrence of chronic subdural hematoma. Front Neurosci 10(6):1–6

    CAS  Google Scholar 

  10. Jiang R, Zhao S, Wang R, Feng H, Zhang J, Li X, Mao Y, Yuan X, Fei Z, Zhao Y, Yu X, Poon WS, Zhu X, Liu N, Kang D, Sun T, Jiao B, Liu X, Yu R, Zhang J, Gao G, Hao J, Su N, Yin G, Zhu X, Lu Y, Wei J, Hu J, Hu R, Li J, Wang D, Wei H, Tian Y, Lei P, Dong JF, Zhang J (2018) Safety and efficacy of atorvastatin for chronic subdural hematoma in Chinese patients: a randomized clinicaltrial. JAMA Neurol 75(11):1338–1346

    Article  Google Scholar 

  11. Chan DYC, Chan DTM, Sun TFD et al (2017) The use of atorvastatin for chronic subdural haematoma: a retrospective cohort comparison study. Br J Neurosurg 31(1):72–77

    Article  Google Scholar 

  12. Tang R, Shi J, Li X et al (2018) Effects of atorvastatin on surgical treatments of chronic subdural hematoma. World Neurosurg 117:e425–e429

    Article  Google Scholar 

  13. Xu M, Chen P, Zhu X, Wang C, Shi X, Yu B (2016) Effects of atorvastatin on conservative and surgical treatments of chronic subdural hematoma in patients. World Neurosurg 91:23–28

    Article  Google Scholar 

  14. Weigel R, Hohenstein A, Schilling L (2014) Vascular endothelial growth factor concentration in chronic subdural hematoma fluid is related to computed tomography appearance and exudation rate. J Neurotrauma 31(7):670–673

    Article  Google Scholar 

  15. Lee KS, Bae WK, Bae HG, Yun IG (2000) The fate of traumatic subdural hygroma in serial computed tomographic scans. J Korean Med Sci 15(5):560–568

    Article  CAS  Google Scholar 

  16. Wang B, Sun L, Tian Y, Li Z, Wei H, Wang D, Yang Z, Chen J, Zhang J, Jiang R (2012) Effects of atorvastatin in the regulation of circulating EPCs and angiogenesis in traumatic brain injury in rats. J Neurol Sci 319(1–2):117–123

    Article  CAS  Google Scholar 

  17. Araujo FA, Rocha MA, Mendes JB et al (2010) Atorvastatin inhibits inflammatory angiogenesis in mice through down regulation of VEGF, TNF-alpha and TGF-beta1. Biomed Pharmacother 64(1):29–34

    Article  CAS  Google Scholar 

  18. Wang D, Li T, Wei H, Wang Y, Yang G, Tian Y, Zhao Z, Wang L, Yu S, Zhang Y, Chen J, Jiang R, Zhang JN (2016) Atorvastatin enhances angiogenesis to reduce subdural hematoma in a rat model. J Neurol Sci 362:91–99

    Article  CAS  Google Scholar 

  19. Liu HF, Qi XW, Ma LL, Yao DK, Wang L (2013) Atorvastatin improves endothelial progenitor cell function and reduces pulmonary hypertension in patients with chronic pulmonary heart disease. Exp Clin Cardiol 18(1):e40–e43

    PubMed  PubMed Central  Google Scholar 

  20. Wang D, Li T, Tian Y, Wang S, Jin C, Wei H, Quan W, Wang J, Chen J, Dong J, Jiang R, Zhang J (2014) Effects of atorvastatin on chronic subdural hematoma: a preliminary report from three medical centers. J Neurol Sci 336(1–2):237–242

    Article  CAS  Google Scholar 

  21. Shofty B, Grossman R (2016) Treatment options for chronic subdural hematoma. World Neurosurgery 87:529–530

    Article  Google Scholar 

  22. Soleman J, Nocera F, Mariani L (2017) The conservative and pharmacological management of chronic subdural haematoma. Swiss Med Wkly 147:w14398

    PubMed  Google Scholar 

Download references

Funding

This work was supported by the National Natural Science Foundation of China (81660734).

Author information

Authors and Affiliations

  1. Department of Genetics, College of Basic Medical Sciences, Jilin University, Changchun, China

    Chang He

  2. Department of Molecular Biology, College of Basic Medical Sciences, Jilin University, Changchun, China

    Chang He

  3. Department of Neurosurgery, The Second Clinical Medical School of Inner Mongolia University for the Nationalities, Hulun Buir, China

    Pengfei Xia

  4. The Key Laboratory of Pathobiology, Ministry of Education, College of Basic Medical Sciences, Jilin University, Changchun, China

    Jinying Xu

  5. Clinical Medicine of Jilin University, Changchun, China

    Lanlan Chen

  6. Department of Ophthalmology, affiliated Hospital of Guangdong Medical University, Zhanjiang, China

    Qiuli Zhang

  7. Guangdong Medical University, Zhanjiang, China

    Qiuli Zhang

Authors
  1. Chang He
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pengfei Xia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jinying Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lanlan Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Qiuli Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Author contributions to the study and manuscript preparation include the following: conception and design: Chang He; analysis and interpretation of data: Pengfei Xia and Chang He; statistical analysis: Chang He; drafting the article: Chang He and Lanlan Chen; critically revising the article: all authors; reviewed submitted version of manuscript: all authors; supervision: Qiuli Zhang.

Corresponding author

Correspondence to Qiuli Zhang.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

Ethical approval is not required for this study.

Informed consent

Informed consent is not required for this study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

He, C., Xia, P., Xu, J. et al. Evaluation of the efficacy of atorvastatin in the treatment for chronic subdural hematoma: a meta-analysis. Neurosurg Rev 44, 479–484 (2021). https://doi.org/10.1007/s10143-019-01218-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10143-019-01218-w

Keywords

Search

Navigation